Showing results (2061-2070 of 10,003) with videos related to
Sort By:
Pageof 1,001
Leukemia & Lymphoma|September 23, 2017
Carfilzomib-dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ENDEAVOR studyHartmut Goldschmidt, Philippe Moreau, Heinz Ludwig, et al.Leukemia & Lymphoma|October 4, 2017
First-line therapy for chronic phase CML: selecting the optimal BCR-ABL1-targeted TKIGiuseppe Saglio, Elias JabbourLeukemia & Lymphoma|October 4, 2017
Proteomics profiling identifies induction of caveolin-1 in chronic lymphocytic leukemia cells by bone marrow stromal cellsHima V Vangapandu, Huiqin Chen, William G Wierda, et al.Leukemia & Lymphoma|August 31, 2017
Responses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapyMadeleine Duvic, Susan E Bates, Richard Piekarz, et al.Leukemia & Lymphoma|September 5, 2017
Prolonged hospitalization, primary refractory disease, performance status and age are prognostic factors for survival in patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantationBente Arboe, Maja Halgren Olsen, Anne Katrine Duun-Henriksen, et al.Leukemia & Lymphoma|September 14, 2017
Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological malignancies, and a potential ace-in-the-hole against antigen-negative relapseKatherine D Cummins, Saar GillLeukemia & Lymphoma|September 14, 2017
Determinants of 1-year survival in critically ill acute leukemia patients: a GRRR-OH studyMárcio Tavares, Virginie Lemiale, Djamel Mokart, et al.Leukemia & Lymphoma|August 30, 2017
Managing multiple myeloma in elderly patientsEvan Diamond, Oscar B Lahoud, Heather LandauLeukemia & Lymphoma|August 30, 2017
All-trans retinoic acid induces autophagic degradation of ubiquitin-like modifier activating enzyme 3 in acute promyelocytic leukemia cellsHuanling Cao, Jing Xie, Lu Guo, et al.Leukemia & Lymphoma|September 8, 2017
The tumor suppressive role of inhibin βA in diffuse large B-cell lymphomaLei Jiang, Ting Si, Mei Yu, et al.Pageof 1,001